Progyny Inc Aktie News

The board of Progyny PGNY, -2.62% has approved a $100 million share-repurchase authorization, its second this year.

NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, announced today that its Board of Directors has approved a share repurchase program to repurchase up to $100 million of its common stock. This follows the program that was previously announced on February 29, 2024. The program will be funded...

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Progyny's executives will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Wednesday, May 15, 2024, at 5:00 P.M. Pacific Time / 8:00 P.M. Eastern Time. They will also participate in a f...

Shares of Progyny Inc. were headed for a record selloff Friday after the fertility-services company said the Supreme Court of Alabama's February ruling regarding in vitro fertilization seemed to scare off some potential customers.

Progyny (NASDAQ: PGNY ) stock is falling hard on Friday after the fertility and family-building benefits solutions company announced earnings results for its first quarter of 2024. The bad news for PGNY investors starts with its revenue of $278.08 million during the quarter.

Progyny, Inc. (NASDAQ:PGNY ) Q1 2024 Earnings Conference Call May 9, 2024 4:45 PM ET Company Participants James Hart – Investor Relations Pete Anevski – Chief Executive Officer Mark Livingston – Chief Financial Officer Michael Sturmer – President Conference Call Participants Anne Samuel – JPMorgan Michael Cherny – Leerink Glen Santangelo – Jefferies Jailendra Singh – Truist Sarah James – Cantor...

Early Sales Activity and New Partnerships Provide Strong Start to Selling Season, Affirming Continued Demand for Fertility and Family Building Solutions Early Sales Activity and New Partnerships Provide Strong Start to Selling Season, Affirming Continued Demand for Fertility and Family Building Solutions

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period ended March 31, 2024 after the close of the market on Thursday, May 9, 2024.